BIODEL INC (BIOD)
 
Quote Price $0.70
Price change for today in $ 0.01
Price change for today in % 2.04
Open Price $0.66
Previous Close $0.69
Daily Range $0.62 - $0.72
52-Week Range $0.50 - $2.16
Volume 42,479
 
 
Brokerage Analyst Recommendations 
4 Brokerage Firms Covering BIOD
 
  
Strong Buy
2 		Buy
0 		Hold
2		 Sell
0		 Strong Sell
0
Average Broker Recommendation (ABR):2 
 
Description
BIODEL INC. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel's product candidates are developed by using VIAdel(TM) technology, which reformulates existing FDA-approved peptide drugs. The Company's lead product candidate, VIAject(TM), is an ultra rapid-acting injectable meal-time insulin in development for use by patients with Type 1 or Type 2 diabetes. VIAject(TM) is currently being tested in two pivotal Phase III clinical trials. Biodel's pipeline also includes VIAtab(TM), a sublingual tablet formulation of insulin in the Phase I stage of clinical testing, and two pre-clinical osteoporosis product candidates.
 
100 SAW MILL ROAD
DANBURY, CT
06810, USA
Phone: 203-796-5000
Fax: 203-796-5001
Web: http://www.biodel.com
Email: shareholder@biodel.com		 Industry:MED-DRUGS
Sector: Medical
Fiscal Year End:September
Last Reported Quarter:03/31/12
Next EPS Date:08/09/12
 
Capital Structure Solvency and Cash Flow
No comments yet. Be the first
make a comment about Capital Structure Solvency and Cash Flow
 
Governance Social Responsibility and Employee Relations
No comments yet. Be the first
make a comment about Governance Social Responsibility and Employee Relations
 
Acquisitions Divestitures and Joint Ventures
No comments yet. Be the first
make a comment about Acquisitions Divestitures and Joint Ventures
 
Recent and Upcoming Events
May 11, 2012 20:53 Biodel Inc. (BIOD) Corporate Event Announcement Notice
May 11, 2012 06:53 Biodel Inc to commence listing common stock on the NASDAQ Capital Market on Friday
May 10, 2012 20:45 Biodel Inc. (BIOD) Corporate Event Announcement Notice
May 10, 2012 15:32 Biodel Announces Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
May 10, 2012 06:00 Biodel Reports Second Quarter Fiscal Year 2012 Financial Results
May 09, 2012 20:45 Biodel Inc. (BIOD) Corporate Event Announcement Notice
May 09, 2012 08:00 BUYINS.NET: LOCM, RNIN, CYCC, PNSN, BIOD, GOK Expected To Be Down After Next Earnings Releases
May 08, 2012 20:45 Biodel Inc. (BIOD) Corporate Event Announcement Notice
May 07, 2012 06:00 Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
May 04, 2012 20:47 Biodel Inc. (BIOD) Corporate Event Announcement Notice
May 03, 2012 20:46 Biodel Inc. (BIOD) Corporate Event Announcement Notice
May 02, 2012 09:54 BUYINS.NET: TRGT, PBIB, FSLR, FSR, NGSX, BIOD Expected To Be Down After Next Earnings Releases
May 02, 2012 06:30 Biodel's Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
Apr 30, 2012 13:49 Stock to Watch: Biodel Down 8.3% (BIOD)
Apr 30, 2012 13:15 Hot Stock: Biodel, Shares Drop 8.3% (BIOD)

 
Major Risks
No comments yet. Be the first
make a comment about Major Risks
 


Created by: WikiMigrationBot. Last Modification: Thursday 03 of June, 2010 06:23:23 CDT by WikiMigrationBot.